Clark Wealth Partners’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.48K Hold
4
– – ﹤0.01% 718
2026
Q2
$1.44K Hold
4
– – ﹤0.01% 456
2026
Q1
$1K Buy
+4
New +$995 ﹤0.01% 523
2025
Q3
– Sell
-16
Closed -$3.5K – 649
2025
Q2
$3.5K Buy
+16
New +$3.42K ﹤0.01% 323
2025
Q1
– Sell
-10
Closed -$3.28K – 616
2024
Q4
$3.28K Buy
+10
New +$3.15K ﹤0.01% 293

Other funds holding WST

Clark Wealth Partners's WST Position: Q3 2026 in Review

Clark Wealth Partners held its West Pharmaceutical (WST) position steady in Q3 2026 at 4 shares worth $1.48K. The position accounts for ﹤0.01% of the portfolio, ranked #718.

Clark Wealth Partners first reported a position in WST in Q4 2024 and has held it in 5 quarters since. The position peaked at $3.5K in Q2 2025. 865 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Clark Wealth Partners held 4 shares of West Pharmaceutical worth $1.48K as of Q3 2026.
  • Clark Wealth Partners left its West Pharmaceutical share count unchanged in Q3 2026.
  • West Pharmaceutical made up ﹤0.01% of Clark Wealth Partners's portfolio in Q3 2026, its #718 holding.
  • Clark Wealth Partners first reported a position in West Pharmaceutical in Q4 2024 and has held it in 5 quarters since.
  • Clark Wealth Partners's West Pharmaceutical position peaked at $3.5K in Q2 2025.
  • 865 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Clark Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.